Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Cariou

Showing results (71-80 of 311) with videos related to

Pageof 32
Sort By:
Annales D'Endocrinologie|August 22, 2018
Expert opinion on immunotherapy induced diabetesSarra Smati, Perrine Buffier, Benjamin Bouillet, et al.
Annales D'Endocrinologie|September 4, 2018
Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitorsPerrine Buffier, Benjamin Bouillet, Sarra Smati, et al.
Diabetes, Obesity & Metabolism|April 25, 2018
Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1-5 trialsMark Warren, Louis Chaykin, David Trachtenbarg, et al.
Current Diabetes Reports|February 16, 2022
COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO StudySarra Smati, Blandine Tramunt, Matthieu Wargny, et al.
Annales D'Endocrinologie|August 27, 2018
Expert opinion on the metabolic complications of mTOR inhibitorsBenjamin Bouillet, Perrine Buffier, Sarra Smati, et al.
Diabetes Care|June 18, 2016
Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical TrialMichael Nauck, Manfredi Rizzo, Andrew Johnson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2024
Prevalence of Liver Steatosis and Fibrosis in Adults With Primary Hypobetaliproteinemia: Results From the HYPOCHOL StudySarra Smati, Matthieu Wargny, Jerome Boursier, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2023
Skewness in Body fat Distribution Pattern Links to Specific Cardiometabolic Disease Risk ProfilesJennifer Linge, Bertrand Cariou, Ian J Neeland, et al.
The Journal of Biological Chemistry|December 1, 2001
Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14Veronique Béréziat, Anne Kasus-Jacobi, Dominique Perdereau, et al.
Atherosclerosis|September 6, 2011
Lack of association between plasma PCSK9 and LDL-apoB100 catabolism in patients with uncontrolled type 2 diabetesBruno Vergès, Laurence Duvillard, Marie Claude Brindisi, et al.
Pageof 32

Showing results (71-80 of 311) with videos related to

Sort By:
Pageof 32
Annales D'Endocrinologie|August 22, 2018
Expert opinion on immunotherapy induced diabetesSarra Smati, Perrine Buffier, Benjamin Bouillet, et al.
Annales D'Endocrinologie|September 4, 2018
Expert opinion on the metabolic complications of new anticancer therapies: Tyrosine kinase inhibitorsPerrine Buffier, Benjamin Bouillet, Sarra Smati, et al.
Diabetes, Obesity & Metabolism|April 25, 2018
Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1-5 trialsMark Warren, Louis Chaykin, David Trachtenbarg, et al.
Current Diabetes Reports|February 16, 2022
COVID-19 and Diabetes Outcomes: Rationale for and Updates from the CORONADO StudySarra Smati, Blandine Tramunt, Matthieu Wargny, et al.
Annales D'Endocrinologie|August 27, 2018
Expert opinion on the metabolic complications of mTOR inhibitorsBenjamin Bouillet, Perrine Buffier, Sarra Smati, et al.
Diabetes Care|June 18, 2016
Once-Daily Liraglutide Versus Lixisenatide as Add-on to Metformin in Type 2 Diabetes: A 26-Week Randomized Controlled Clinical TrialMichael Nauck, Manfredi Rizzo, Andrew Johnson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 6, 2024
Prevalence of Liver Steatosis and Fibrosis in Adults With Primary Hypobetaliproteinemia: Results From the HYPOCHOL StudySarra Smati, Matthieu Wargny, Jerome Boursier, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2023
Skewness in Body fat Distribution Pattern Links to Specific Cardiometabolic Disease Risk ProfilesJennifer Linge, Bertrand Cariou, Ian J Neeland, et al.
The Journal of Biological Chemistry|December 1, 2001
Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14Veronique Béréziat, Anne Kasus-Jacobi, Dominique Perdereau, et al.
Atherosclerosis|September 6, 2011
Lack of association between plasma PCSK9 and LDL-apoB100 catabolism in patients with uncontrolled type 2 diabetesBruno Vergès, Laurence Duvillard, Marie Claude Brindisi, et al.
Pageof 32